Loading...

Landec Corporation

LNDCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.76
$-0.32(-3.52%)

Landec Corporation LNDC Peers

See (LNDC) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LNDC$8.76-3.52%263.6M-4.04-$2.17N/A
ZTS$159.08-0.07%70.8B28.61$5.56+1.17%
TAK$15.42+0.33%48.6B67.11$0.23+3.82%
HLN$10.26-0.92%46.2B23.88$0.43+1.14%
TEVA$17.05+2.46%19.6B-14.83-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$129.40+1.09%12.8B43.89$2.95N/A
RDY$14.88-0.40%12.4B19.07$0.78+0.65%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$9.34+1.74%11B-2.94-$3.18+5.15%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LNDC vs ZTS Comparison

LNDC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LNDC stands at 263.6M. In comparison, ZTS has a market cap of 70.8B. Regarding current trading prices, LNDC is priced at $8.76, while ZTS trades at $159.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LNDC currently has a P/E ratio of -4.04, whereas ZTS's P/E ratio is 28.61. In terms of profitability, LNDC's ROE is +2.28%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, LNDC is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for LNDC.

Stock Price Comparison

Loading...

Frequently Asked Questions

;